MarketPeel
Insider Trading Intelligence
MH

Michael F. Huang

SLNO
SR. VP OF CLINICAL DEVELOPMENT · SOLENO THERAPEUTICS INC · CIK 0002019992
FILING MIX · LIFETIME25%/75%
BUYS
6
SELLS
18
TOTAL VALUE
$1.47M
COMPANIES
1
ACTIVE SINCE
Jul 2024
HOLDINGS NOW
0
AVG SELL PX
$57.08
TRADE KIND
SHOWING 24 / 24
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
12 backtested trades · 8 horizons · 18 pending
Forward-return performance of every backtestable P/S trade by Michael F. Huang, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d12+0.00%+13.16%-3.16%+16.32%+12.44%
14d12+75.00%+13.76%-3.83%+17.59%+0.79%
30d12+0.00%+25.42%+1.02%+24.40%+11.61%
60d12+0.00%+13.16%+4.25%+8.92%+8.92%
90d12+0.00%+27.30%+9.21%+20.24%+20.24%
180d12(3 pending)+100.00%-15.64%+16.95%-32.59%-32.59%
1y12(3 pending)+100.00%-55.41%+11.82%-67.22%-67.22%
2y12(12 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
SLNO · 0 shares · as of May 18, 2026
027,50055,00082,500110,00020252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 6 buys / 18 sellsCOVERAGE · 8 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
SLNO
SOLENO THERAPEUTICS INC
SALE
Sr. VP of Clinical Development
39,8230May 18, 2026May 18, 2026View →
SLNO
SOLENO THERAPEUTICS INC
SALE
Sr. VP of Clinical Development
13,8000May 18, 2026May 18, 2026View →
SLNO
SOLENO THERAPEUTICS INC
SALE
Sr. VP of Clinical Development
110,0000May 18, 2026May 18, 2026View →
SLNO
SOLENO THERAPEUTICS INC
SALE
Sr. VP of Clinical Development
11,9000May 18, 2026May 18, 2026View →
SLNO
SOLENO THERAPEUTICS INC
SALE
Sr. VP of Clinical Development
488$31.72$15.5K39,823Mar 27, 2026Mar 31, 2026View →
SLNO
SOLENO THERAPEUTICS INC
SALE
Sr. VP of Clinical Development
4,256$30.04$127.8K42,149Mar 27, 2026Mar 31, 2026View →
SLNO
SOLENO THERAPEUTICS INC
SALE
Sr. VP of Clinical Development
1,838$31.04$57.0K40,311Mar 27, 2026Mar 31, 2026View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASEGRANT
Stock grant
10,40046,405Jan 21, 2026Jan 23, 2026View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASEGRANT
Stock grant
11,90011,900Jan 21, 2026Jan 23, 2026View →
SLNO
SOLENO THERAPEUTICS INC
SALE
Sr. VP of Clinical Development
812$49.95$40.6K36,005Dec 15, 2025Dec 17, 2025View →
SLNO
SOLENO THERAPEUTICS INC
SALE
Sr. VP of Clinical Development
125$71.74$9.0K36,836Mar 27, 2025Mar 31, 2025View →
SLNO
SOLENO THERAPEUTICS INC
SALE
Sr. VP of Clinical Development
836$69.84$58.4K37,047Mar 27, 2025Mar 31, 2025View →
SLNO
SOLENO THERAPEUTICS INC
SALE
Sr. VP of Clinical Development
19$72.64$1.4K36,817Mar 27, 2025Mar 31, 2025View →
SLNO
SOLENO THERAPEUTICS INC
SALE
Sr. VP of Clinical Development
86$70.73$6.1K36,961Mar 27, 2025Mar 31, 2025View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASE
Sr. VP of Clinical Development
10,000$21.93$219.3K46,817Mar 27, 2025Mar 31, 2025View →
SLNO
SOLENO THERAPEUTICS INC
SALE
Sr. VP of Clinical Development
1,098$67.70$74.3K39,327Mar 27, 2025Mar 31, 2025View →
SLNO
SOLENO THERAPEUTICS INC
SALE
Sr. VP of Clinical Development
10,000110,000Mar 27, 2025Mar 31, 2025View →
SLNO
SOLENO THERAPEUTICS INC
SALE
Sr. VP of Clinical Development
10,000$70.03$700.3K36,817Mar 27, 2025Mar 31, 2025View →
SLNO
SOLENO THERAPEUTICS INC
SALE
Sr. VP of Clinical Development
1,444$68.79$99.3K37,883Mar 27, 2025Mar 31, 2025View →
SLNO
SOLENO THERAPEUTICS INC
SALE
Sr. VP of Clinical Development
371$65.97$24.5K41,029Mar 27, 2025Mar 31, 2025View →
SLNO
SOLENO THERAPEUTICS INC
SALE
Sr. VP of Clinical Development
604$66.79$40.3K40,425Mar 27, 2025Mar 31, 2025View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASEGRANT
Stock grant
13,80013,800Jan 21, 2025Jan 23, 2025View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASEGRANT
Stock grant
6,40041,400Jan 21, 2025Jan 23, 2025View →
SLNO
SOLENO THERAPEUTICS INC
PURCHASEGRANT
Stock grant
35,00035,000Jul 17, 2024Jul 19, 2024View →
Other insiders · SLNO
Loading peer insiders…
About this filer
CIK 0002019992
ROLE
Sr. VP of Clinical Development
PRIMARY
SLNO
COMPANIES
1
ACTIVE SINCE
Jul 2024
MARKETPEEL · /INSIDER/0002019992DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback